306 related articles for article (PubMed ID: 31517711)
21. Economic impact model of delayed inhibitor development in patients with hemophilia a receiving emicizumab for the prevention of bleeding events.
Patel AM; Corman SL; Chaplin S; Raimundo K; Sidonio RF
J Med Econ; 2019 Dec; 22(12):1328-1337. PubMed ID: 31530050
[No Abstract] [Full Text] [Related]
22. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
23. New therapies for hemophilia.
Weyand AC; Pipe SW
Blood; 2019 Jan; 133(5):389-398. PubMed ID: 30559264
[TBL] [Abstract][Full Text] [Related]
24. [Successful treatment by switching from activated prothrombin complex concentrate to emicizumab therapy in a hemophilia A patient with inhibitors].
Sakamoto A; Nakadate H; Watanabe N; Ishiguro A
Rinsho Ketsueki; 2020; 61(6):617-620. PubMed ID: 32624534
[TBL] [Abstract][Full Text] [Related]
25. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.
Coppola A; Tagliaferri A; Rivolta GF; Quintavalle G; Franchini M
Semin Thromb Hemost; 2020 Oct; 46(7):819-822. PubMed ID: 32512586
[No Abstract] [Full Text] [Related]
26. Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms.
Lillicrap D; Fijnvandraat K; Young G; Mancuso ME
Expert Rev Hematol; 2020 Apr; 13(4):313-321. PubMed ID: 32186928
[No Abstract] [Full Text] [Related]
27. Articular Bleeding in Hemophilia.
Rodriguez-Merchan EC
Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):21-24. PubMed ID: 28049407
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations.
Valentino LA; Khair K
Expert Rev Hematol; 2020 Jul; 13(7):731-743. PubMed ID: 32573295
[TBL] [Abstract][Full Text] [Related]
29. Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.
Díaz-Ricart M; Isola IM; Escolar G
Drugs Today (Barc); 2018 Oct; 54(10):591-600. PubMed ID: 30398480
[TBL] [Abstract][Full Text] [Related]
30. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
31. The promise and challenges of bioengineered recombinant clotting factors.
Pipe SW
J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035
[TBL] [Abstract][Full Text] [Related]
32. [Emicizumab: a paradigm shift in hemophilia treatment].
Nogami K
Rinsho Ketsueki; 2020; 61(5):536-541. PubMed ID: 32507821
[TBL] [Abstract][Full Text] [Related]
33. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding.
Pasca S; Zanon E; Mannucci PM; Peyvandi F
Blood Transfus; 2023 Nov; 21(6):549-556. PubMed ID: 36795341
[TBL] [Abstract][Full Text] [Related]
34. Emicizumab for hemophilia A without inhibitors.
Cafuir L; Kruse-Jarres R; Mancuso ME; Kempton CL
Expert Rev Hematol; 2019 Jul; 12(7):515-524. PubMed ID: 31130012
[No Abstract] [Full Text] [Related]
35. Toward optimal therapy for inhibitors in hemophilia.
Kempton CL; Meeks SL
Blood; 2014 Nov; 124(23):3365-72. PubMed ID: 25428222
[TBL] [Abstract][Full Text] [Related]
36. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.
Teitel JM; Sholzberg M
Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718
[TBL] [Abstract][Full Text] [Related]
37. Use of high dose factor VIIa in hemophilia patients.
Hedner U
Adv Exp Med Biol; 2001; 489():75-88. PubMed ID: 11554593
[No Abstract] [Full Text] [Related]
38. Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.
McCary I; Guelcher C; Kuhn J; Butler R; Massey G; Guerrera MF; Ballester L; Raffini L
Haemophilia; 2020 Jul; 26(4):631-636. PubMed ID: 32311809
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of acquired haemophilia.
Baudo F; Caimi T; de Cataldo F
Haemophilia; 2010 May; 16(102):102-6. PubMed ID: 20536992
[TBL] [Abstract][Full Text] [Related]
40. Current concepts in diagnosis and management of hemophilia.
Aledort LM
Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
